scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1104297737 |
P356 | DOI | 10.1038/S41398-018-0161-3 |
P932 | PMC publication ID | 5976668 |
P698 | PubMed publication ID | 29849049 |
P50 | author | Enrique J deAndrés-Galiana | Q55445073 |
Rebekah Feng | Q56955836 | ||
Juan Fernandez-Martinez | Q59698558 | ||
P2093 | author name string | Leorey N Saligan | |
Kristien J M Zaal | |||
Brian S Wolff | |||
P2860 | cites work | RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes | Q22008771 |
Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5 | Q30500964 | ||
The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. | Q31725223 | ||
Cancer-Related Fatigue, Version 2.2015. | Q33878583 | ||
Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer | Q33910359 | ||
Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome | Q33936937 | ||
Glutamate as a neurotransmitter in the healthy brain | Q34048502 | ||
Neutrophil-derived glutamate regulates vascular endothelial barrier function | Q34114299 | ||
Functional domains and DNA-binding sequences of RFLAT-1/KLF13, a Krüppel-like transcription factor of activated T lymphocytes | Q34131917 | ||
The Fli-1 transcription factor regulates the expression of CCL5/RANTES | Q34146504 | ||
Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation | Q34325464 | ||
Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. | Q34564332 | ||
The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy | Q34596902 | ||
Supervised classification by filter methods and recursive feature elimination predicts risk of radiotherapy-related fatigue in patients with prostate cancer | Q34609499 | ||
Cytokine-induced sickness behavior: mechanisms and implications | Q34631070 | ||
Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cells. | Q35092600 | ||
STIM1 controls T cell-mediated immune regulation and inflammation in chronic infection | Q35899422 | ||
HIV-1 infection and AIDS: consequences for the central nervous system | Q36098879 | ||
Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems | Q36306674 | ||
Upregulation of α-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways | Q36456667 | ||
Plasma glutamate-modulated interaction of A2AR and mGluR5 on BMDCs aggravates traumatic brain injury-induced acute lung injury | Q36750067 | ||
Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications | Q37370372 | ||
Intracellular metabotropic glutamate receptor 5 (mGluR5) activates signaling cascades distinct from cell surface counterparts | Q37467712 | ||
The neuroimmune basis of fatigue | Q37470201 | ||
Mechanisms Associated with Activation of Intracellular Metabotropic Glutamate Receptor, mGluR5. | Q37616404 | ||
The immunological synapse, TCR microclusters, and T cell activation | Q37644268 | ||
Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications | Q37688991 | ||
Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury | Q37693239 | ||
Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues | Q37828015 | ||
Cyclic AMP: a selective modulator of NF-κB action. | Q37899788 | ||
The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells | Q38192495 | ||
Portrait of inflammatory response to ionizing radiation treatment. | Q38364169 | ||
Clinical Predictors of Fatigue in Men With Non-Metastatic Prostate Cancer Receiving External Beam Radiation Therapy. | Q38638440 | ||
The role of inflammation in depression: from evolutionary imperative to modern treatment target | Q38681725 | ||
Group I mGlu receptor stimulation inhibits activation-induced cell death of human T lymphocytes. | Q38758299 | ||
Exploratory Investigation of Early Biomarkers for Chronic Fatigue in Prostate Cancer Patients Following Radiation Therapy. | Q38815010 | ||
Ionizing radiation-induced NF-kappaB activation requires PARP-1 function to confer radioresistance | Q39908141 | ||
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial | Q42167679 | ||
Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation. | Q42958588 | ||
Neuroprotective immunity: T cell-derived glutamate endows astrocytes with a neuroprotective phenotype | Q46717069 | ||
Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients | Q46981453 | ||
Different Phenotyping Approaches Lead to Dissimilar Biologic Profiles in Men With Chronic Fatigue After Radiation Therapy | Q50308378 | ||
Radiation oncology: a century of achievements. | Q55038981 | ||
Glutamate Released by Dendritic Cells as a Novel Modulator of T Cell Activation | Q62399771 | ||
Homer proteins regulate coupling of group I metabotropic glutamate receptors to N-type calcium and M-type potassium channels | Q73011082 | ||
Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system | Q73206828 | ||
Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales | Q78846097 | ||
The excitotoxic effect of NMDA on human lymphocyte immune function | Q80418018 | ||
The role of TRAIL in fatigue induced by repeated stress from radiotherapy | Q87671063 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P304 | page(s) | 110 | |
P577 | publication date | 2018-05-30 | |
P1433 | published in | Translational Psychiatry | Q15716636 |
P1476 | title | mGluR5 mediates post-radiotherapy fatigue development in cancer patients. | |
P478 | volume | 8 |
Q92586723 | Cognitive and motor aspects of cancer-related fatigue |
Q59130028 | Encephalitis Associated to Metabotropic Glutamate Receptor 5 (mGluR5) Antibodies in Cerebrospinal Fluid |
Q92857748 | Fatigue, Sleep, and Autoimmune and Related Disorders |
Q89885736 | Precision health: A nursing perspective |
Q90273154 | Robust pathway sampling in phenotype prediction. Application to triple negative breast cancer |
Search more.